These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26589942)

  • 41. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
    Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
    Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.
    Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui WO
    Br J Cancer; 2014 Nov; 111(11):2091-102. PubMed ID: 25349971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors.
    Schwamb B; Pick R; Fernández SB; Völp K; Heering J; Dötsch V; Bösser S; Jung J; Beinoraviciute-Kellner R; Wesely J; Zörnig I; Hammerschmidt M; Nowak M; Penzel R; Zatloukal K; Joos S; Rieker RJ; Agaimy A; Söder S; Reid-Lombardo KM; Kendrick ML; Bardsley MR; Hayashi Y; Asuzu DT; Syed SA; Ordog T; Zörnig M
    Int J Cancer; 2015 Sep; 137(6):1318-29. PubMed ID: 25716227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
    Tang M; Li DQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The roles of APOBEC3B in gastric cancer.
    Zhang J; Wei W; Jin HC; Ying RC; Zhu AK; Zhang FJ
    Int J Clin Exp Pathol; 2015; 8(5):5089-96. PubMed ID: 26191203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analyzing the molecular mechanism of the tissue specificity of gastrointestinal stromal tumors by using bioinformatics approaches.
    Ma N; Xu H; Zhou Y; Liu M; Wei Zhou J; Jie Wang C
    J BUON; 2018; 23(4):1149-1155. PubMed ID: 30358224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.
    Zhang ZH; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Ibusuki M; Tomita S; Sugiura H; Kobayashi S; Fujii Y; Iwase H
    Chin Med J (Engl); 2009 Aug; 122(15):1764-8. PubMed ID: 19781322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade.
    Baron BW; Hyjek E; Gladstone B; Thirman MJ; Baron JM
    Blood Cells Mol Dis; 2010 Aug; 45(2):169-75. PubMed ID: 20605493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
    Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
    Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinicopathological and molecular features of the gastrointestinal stromal tumor].
    Sugai T; Uesugi N; Yamada N; Takahashi K; Wakabayashi G; Terashima M; Chiba T; Suzuki K
    Gan To Kagaku Ryoho; 2011 May; 38(5):715-21. PubMed ID: 21566429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of TGF-β1 in Gastrointestinal Stromal Tumor (GIST) and the Occurrence of Frequent Desmoplasia.
    Mochizuki K; Oishi N; Tahara I; Inoue T; Kondo T
    Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):229-232. PubMed ID: 38584487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacy.
    Van Looy T; Wozniak A; Floris G; Sciot R; Li H; Wellens J; Vanleeuw U; Fletcher JA; Manley PW; Debiec-Rychter M; Schöffski P
    Clin Cancer Res; 2014 Dec; 20(23):6071-82. PubMed ID: 25316817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor.
    Ran L; Chen Y; Sher J; Wong EWP; Murphy D; Zhang JQ; Li D; Deniz K; Sirota I; Cao Z; Wang S; Guan Y; Shukla S; Li KY; Chramiec A; Xie Y; Zheng D; Koche RP; Antonescu CR; Chen Y; Chi P
    Cancer Discov; 2018 Feb; 8(2):234-251. PubMed ID: 29162563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imatinib mesylate induces quiescence in gastrointestinal stromal tumor cells through the CDH1-SKP2-p27Kip1 signaling axis.
    Liu Y; Perdreau SA; Chatterjee P; Wang L; Kuan SF; Duensing A
    Cancer Res; 2008 Nov; 68(21):9015-23. PubMed ID: 18974147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ?
    Giuliano K; Nagarajan N; Canner J; Najafian A; Wolfgang C; Schneider E; Meyer C; Lennon AM; Johnston FM; Ahuja N
    J Surg Oncol; 2017 Mar; 115(3):351-357. PubMed ID: 27885685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
    Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups.
    Liu Y; Li Z; Xu Z; Jin X; Gong Y; Xia X; Yao Y; Xu Z; Zhou Y; Xu H; Li S; Peng Y; Wu X; Dai L
    Mol Cell Proteomics; 2019 May; 18(5):923-935. PubMed ID: 30804049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial‑mesenchymal transition.
    Liu H; Wang M; Liang N; Guan L
    Mol Med Rep; 2019 Mar; 19(3):2173-2179. PubMed ID: 30664177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.